These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12029547)

  • 21. Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours.
    Melis M; Bijster M; de Visser M; Konijnenberg MW; de Swart J; Rolleman EJ; Boerman OC; Krenning EP; de Jong M
    Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):1968-76. PubMed ID: 19585115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preclinical evaluation of technetium-99m-labeled somatostatin receptor-binding peptides.
    Vallabhajosula S; Moyer BR; Lister-James J; McBride BJ; Lipszyc H; Lee H; Bastidas D; Dean RT
    J Nucl Med; 1996 Jun; 37(6):1016-22. PubMed ID: 8683294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spacer effects on in vivo properties of DOTA-conjugated dimeric [Tyr3]octreotate peptides synthesized by a "Cu(I)-click" and "sulfo-click" ligation method.
    Yim CB; van der Wildt B; Dijkgraaf I; Joosten L; Eek A; Versluis C; Rijkers DT; Boerman OC; Liskamp RM
    Chembiochem; 2011 Mar; 12(5):750-60. PubMed ID: 21328514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
    De Jong M; Bakker WH; Breeman WA; Bernard BF; Hofland LJ; Visser TJ; Srinivasan A; Schmidt M; Béhé M; Mäcke HR; Krenning EP
    Int J Cancer; 1998 Jan; 75(3):406-11. PubMed ID: 9455802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
    Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
    Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation and biological evaluation of [(99m)Tc/EDDA/Tricine/HYNIC(0), BzThi(3)]-octreotide for somatostatin receptor-positive tumor imaging.
    Erfani M; Shafiei M; Mazidi M; Goudarzi M
    Cancer Biother Radiopharm; 2013 Apr; 28(3):240-7. PubMed ID: 23464855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors.
    Eisenwiener KP; Prata MI; Buschmann I; Zhang HW; Santos AC; Wenger S; Reubi JC; Mäcke HR
    Bioconjug Chem; 2002; 13(3):530-41. PubMed ID: 12009943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two Novel Nanosized Radiolabeled Analogues of Somatostatin for Neuroendocrine Tumor Imaging.
    Orocio-Rodríguez E; Ferro-Flores G; Santos-Cuevas CL; Ramírez Fde M; Ocampo-García BE; Azorín-Vega E; Sánchez-García FM
    J Nanosci Nanotechnol; 2015 Jun; 15(6):4159-69. PubMed ID: 26369025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour uptake of the radiolabelled somatostatin analogue [DOTA0, TYR3]octreotide is dependent on the peptide amount.
    de Jong M; Breeman WA; Bernard BF; van Gameren A; de Bruin E; Bakker WH; van der Pluijm ME; Visser TJ; Mäcke HR; Krenning EP
    Eur J Nucl Med; 1999 Jul; 26(7):693-8. PubMed ID: 10398816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A; Krenning E; Bernard B; Reubi JC; Breeman W; de Jong M
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET.
    Henriksen G; Schottelius M; Poethko T; Hauser A; Wolf I; Schwaiger M; Wester HJ
    Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1653-7. PubMed ID: 15309330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (99m)Tc-labeled dimeric octreotide peptide: a radiotracer with high tumor uptake for single-photon emission computed tomography imaging of somatostatin receptor subtype 2-positive tumors.
    Dong C; Zhao H; Yang S; Shi J; Huang J; Cui L; Zhong L; Jin X; Li F; Liu Z; Jia B; Wang F
    Mol Pharm; 2013 Aug; 10(8):2925-33. PubMed ID: 23768172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model.
    Schmitt A; Bernhardt P; Nilsson O; Ahlman H; Kölby L; Forssell-Aronsson E
    Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioiodine and 211At-labeled guanidinomethyl halobenzoyl octreotate conjugates: potential peptide radiotherapeutics for somatostatin receptor-positive cancers.
    Vaidyanathan G; Boskovitz A; Shankar S; Zalutsky MR
    Peptides; 2004 Dec; 25(12):2087-97. PubMed ID: 15572196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. A new somatostatin analog with improved target tissue uptake.
    Lewis JS; Srinivasan A; Schmidt MA; Anderson CJ
    Nucl Med Biol; 1999 Apr; 26(3):267-73. PubMed ID: 10363797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy.
    Li WP; Lewis JS; Kim J; Bugaj JE; Johnson MA; Erion JL; Anderson CJ
    Bioconjug Chem; 2002; 13(4):721-8. PubMed ID: 12121126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics.
    Wester HJ; Schottelius M; Scheidhauer K; Reubi JC; Wolf I; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2002 Jan; 29(1):28-38. PubMed ID: 11807604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [99mTc-octreotide receptor scintigraphy in NCI-H446 small cell lung cancer nude mice model].
    Li C; Zuo S; Wang X; Liu X; Wang G; Wu F
    Zhongguo Fei Ai Za Zhi; 2015 Jan; 18(1):1-7. PubMed ID: 25603866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and characterisation of [90Y]-Bz-DTPA-oct: a yttrium-90-labelled octreotide analogue for radiotherapy of somatostatin receptor-positive tumours.
    Smith-Jones PM; Stolz B; Albert R; Ruser G; Briner U; Mäcke HR; Bruns C
    Nucl Med Biol; 1998 Apr; 25(3):181-8. PubMed ID: 9620621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New octreotide derivatives for in vivo targeting of somatostatin receptor-positive tumors for single photon emission computed tomography (SPECT) and positron emission tomography (PET).
    Mäcke HR; Smith-Jones P; Maina T; Stolz B; Albert R; Bruns C; Reist H
    Horm Metab Res Suppl; 1993; 27():12-7. PubMed ID: 8392486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.